关键词: LMNA NTRK NTRK1 lipofibromatosis-like neural tumor

Mesh : Adult Dermatofibrosarcoma / diagnosis genetics metabolism pathology Diagnosis, Differential Female Gene Rearrangement Humans Lamin Type A / genetics metabolism Neoplasms, Nerve Tissue / diagnosis genetics metabolism pathology Oncogene Proteins, Fusion / genetics metabolism Receptor, trkA / genetics metabolism Skin Neoplasms / diagnosis genetics metabolism pathology

来  源:   DOI:10.1111/cup.13772   PDF(Sci-hub)

Abstract:
We present the case of a 31-year-old female with a 1.5 cm pigmented nodule on the scalp. Histopathological examination revealed a proliferation of relatively bland spindle cells and pigmented dendritic cells, with interspersed lymphoid follicles diffusely infiltrating the adipose tissue. The microscopic differential diagnosis included pigmented dermatofibrosarcoma protuberans (DFSP). The spindle cells showed S-100 and CD34 labeling but were negative for SOX-10. Immunohistochemical stain for pan-TRK was positive, while fluorescence in-situ hybridization for PDGFB gene rearrangement was negative. Targeted RNA sequencing revealed an LMNA-NTRK1 (exon2/exon10) fusion. This molecular result coupled with the histopathological findings and immunohistochemical profile supported the diagnosis of the recently characterized NTRK-rearranged spindle cell neoplasm termed \"lipofibromatosis-like neural tumor (LPF-NT).\" These neoplasms typically occur in superficial soft tissue and are characterized by a distinctive immunoprofile (CD34+, S-100+, SOX10-). Histopathological differential diagnosis for LPF-NT tumors includes lipofibromatosis, DFSP, low-grade malignant peripheral nerve sheath tumor, and spindle cell/desmoplastic melanoma. The pigmented dendritic cells reminiscent of pigmented DFSP and lymphoid follicles noted in our case have not been previously reported in LPF-NT, thus expanding the morphological spectrum of this entity. LMNA-NTRK1 fusion serves both as a diagnostic and therapeutic biomarker, as cases with advanced disease may be amenable to targeted therapy using tyrosine kinase inhibitors.
摘要:
暂无翻译
公众号